Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
3.250
-0.030 (-0.91%)
Jul 25, 2025, 4:00 PM - Market closed
AVR Employees
Anteris Technologies Global had 136 employees as of December 31, 2024.
Employees
136
Change
n/a
Growth
n/a
Revenue / Employee
$18,331
Profits / Employee
-$601,507
Market Cap
114.71M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 136 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AVR News
- 6 weeks ago - Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewsWire
- 4 months ago - Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewsWire
- 4 months ago - Anteris Reports One-Year Patient Outcomes for DurAVR® THV - GlobeNewsWire
- 4 months ago - Anteris Reports 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering - Business Wire
- 8 months ago - Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering - Business Wire
- 8 months ago - Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering - Business Wire
- 8 months ago - Cardiac device maker Anteris Technologies files for $75M IPO - Seeking Alpha